Clearance Summary
CI-TROL COAGULATION CONTROLS II & III received FDA 510(k) clearance under submission number K771346, sponsored by Dade, Baxter Travenol Diagnostics, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1977-08-22.
- Submission: K771346
- Applicant / Sponsor: Dade, Baxter Travenol Diagnostics, Inc.
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.5425
- Decision date: 1977-08-22
Classification & Regulation
This clearance is catalogued under FDA product code GGN and 21 CFR 864.5425, within the Hematology review panel as a Class II device.